Skip to main content

Table 3 Univariable and multivariable Cox proportional hazards regression analysis for PFS and OS in the original cohort

From: Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study

Variables

PFS

OS

Univariable

Multivariable

Univariable

Multivariable

Median PFS (mo)

P

HR (95% CI)

P

Median OS (mo)

P

HR (95% CI)

P

Sex

 

0.385

   

0.980

  

 Male

3

   

24

   

 Female

4

   

18

   

Age

 

0.251

   

0.128

  

 ≤60

4

   

22

   

 >60

4

   

15

   

Primary tumor site

 

0.056

1.37 (0.75, 2.51)

0.300

 

0.011

1.47 (0.67, 2.80)

0.241

 Colon

5

   

31

   

 Rectum

2

   

9

   

Grade

 

0.227

   

< 0.001

1.99 (0.50, 7.84)

0.326

 G1 and G2

5

   

88

   

 G3

3

   

11

   

Differentiation

 

0.012

1.86 (1.02, 3.41)

0.043

 

< 0.001

3.70 (1.09–12.48)

0.035

 NET

9

   

62

   

 NEC

2

   

9

   

Clinical T stage

 

0.724

   

0.745

  

 T1, T2

5

   

21

   

 T3, T4

4

   

22

   

Clinical N stage

 

0.340

   

0.318

  

 N0

3

   

62

   

 N1

4

   

21

   

Site of metastasis

 

0.861

   

0.310

  

 Single-organ

4

   

26

   

 Multiple-organ

4

   

18

   

PTR

 

0.578

   

0.964

  

 Yes

4

   

24

   

 No

4

   

16

   
  1. PFS: progression free survival, OS: overall survival, HR: hazards ratio, CI: confidence interval, NET: neuroendocrine tumor, NEC: neuroendocrine carcinoma, PTR: primary tumor resection